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Background: Vasopressin administration has been tested in cardiac arrest. However it has not been tested when
cardiac arrest occurs in certain circumstances, as in sepsis, where it may have a major role. The aim of the study
was to investigate survival after cardiac arrest in a septic porcine model compared with healthy animals and to
explore the effectiveness of adding vasopressin vs epinephrine alone administration.
Methods: Thirty five healthy piglets of both genders were studied. The piglets were randomly assigned into three
groups: group A (n = 8), group B (n = 14), group C (n = 13). Animals of groups B and C were given endotoxin to
mimic a septic state before arrest. We applied the same resuscitation protocol to all pigs but we replaced the first
dose of epinephrine with vasopressin in pigs of group C. Following surgical preparation and 30 min resting period,
baseline measurements were recorded. In order to assess tissue oxygenation, we implemented Near Infrared
Spectroscopy (NIRS) with the vascular occlusion technique (VOT) in thirteen lipopolysaccharide (LPS)-treated
animals, occluding abdominal aorta and inferior vena cava. Afterwards, LPS (100 μg/kg) was infused in a 30 min
period to animals of groups B and C and normal saline to group A. New NIRS measurements were obtained again.
Subsequently, we provoked ventricular fibrillation (VF). After 3 min of untreated VF, open chest cardiopulmonary
resuscitation (CPR) was performed manually. Primary end point was the restoration of spontaneous circulation
(ROSC).
Results: The chance of ROSC for the groups A, B and C was 75%, 35.7%, and 30.7% respectively. A significant
difference in ROSC was established between septic (group B + C) and non septic piglets (group A) (P = 0.046).
Vasopressin administration had no effect in outcome. LPS administration decreased oxygen consumption rate,
as assessed by NIRS, in peripheral tissues (22.6 ± 7.2. vs 18.5 ± 7.2, P = 0.07).
Conclusion: Septic piglets have fewer chances to survive after cardiac arrest. No difference in outcome was
observed when the first dose of epinephrine was replaced with vasopressin to treat cardiac arrest in the LPS-treated
animals.
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Sepsis is a major health problem worldwide, especially in
Intensive Care Units (ICUs). Its incidence and the sepsis-
related mortality are gradually increasing [1].
Sepsis syndrome adversely affects microcirculation [2]
as well as mitochondrial respiration [3], compromising
oxygen availability and utilization in tissues. In experi-
mental animal studies, bacterial cell wall lipopolysac-
charide (LPS) is used to induce endotoxemia and create
a sepsis-like state. LPS infusion induces similarly micro-
circulatory alterations [4] and inhibits mitochondrial
respiration and oxygen consumption rate even in the
early stages after infusion [5].
Surviving sepsis campaign for management of severe
sepsis and septic shock suggests that arginine-vasopressin
(AVP, up to 0.03 U/min) can be added to norepinephrine
(NE) in order to raise mean arterial pressure and decrease
NE dosage [6]. Rationales for AVP use are mainly a rela-
tive deficiency of AVP in septic shock and improved
hemodynamics, as AVP restores the vascular reactivity to
catecholamines, which is reduced, and decreases catechol-
amines requirements [7,8].
A vasopressor during cardiopulmonary resuscitation
(CPR) after cardiac arrest (CA) is used to enhance aortic
diastolic pressure and, thus, coronary perfusion pressure
and blood flow, as well as cerebral blood flow.
Theoretically, together with effective CPR, an optimal
vasopressor should ensure adequate oxygen delivery and
not increase oxygen demands, which may set tissues in
an oxygen deficient state and hazard tissue viability and
function. It has been proposed [9] that depletion of myo-
cardial energy stores after 3–4 min of CA can comprom-
ise the ability of the heart to resume organized systolic
function after defibrillation.
Epinephrine (EP) and AVP have been tested in CA. EP
increases coronary perfusion pressure via α-adrenergic me-
diated vasoconstriction. However EP exerts β1-adrenergic
cardiac stimulation, which promotes adverse cardiac effects
as increased myocardial oxygen consumption, ventricular
arrhythmias and post-resuscitation myocardial dysfunction,
and its role as the primary drug administered during CPR
has been challenged [10]. Beta-adrenergic blockade during
CPR in experimental animal studies resulted in improved
restoration of spontaneous circulation (ROSC) after ven-
tricular fibrillation (VF), minimized post-resuscitation myo-
cardial dysfunction and improved survival [11].
Thus, AVP, which does not exert adverse cardiac ef-
fects as EP, seems advantageous over EP.
However, robust evidence, provided by randomized,
controlled trials, in the literature, do not support a bene-
ficial effect of either AVP or EP administration in CA
compared to the other or their combination [12,13].
In the present study we estimated the effect of LPS ad-
ministration in tissues, with regard to tissue oxygenation,utilizing Near Infrared Spectroscopy (NIRS). NIRS is a
non-invasive method utilized to assess tissue oxygenation
[14]. It has been used to assess microcirculatory derange-
ments after LPS administration [15]. Also, in septic ICU
patients NIRS measurements track changes of tissue oxy-
genation and are related with the severity of sepsis [16]. In
a recent study, NIRS was also used in a porcine model of
CA, to evaluate peripheral tissue oxygenation at arrest
and during CPR [17].
We hypothesized that the viability of tissues in septic
animal models, induced by LPS administration, would be
compromised after CA and resuscitation efforts, com-
pared with intact animals also suffering CA, due to the
impaired aerobic metabolism in the former group, and
would result in a decreased chance of ROSC after CPR
and Advanced Life Support treatment implementation.
We aimed to investigate ROSC likelihood after CA in
an endotoxemic porcine model compared with non-
LPS-treated pigs. Also, considering the theoretical ad-
vantages of AVP use over catecholamines in endotoxe-
mia/sepsis, we aimed to check the outcome replacing
the first dose of EP with AVP during CPR.
Methods
Animal preparation
The experimental protocol was approved by the General
Directorate of Veterinary Services (permit No 5683/8-1-
2008) according to Greek legislation, with regard to eth-
ical and experimental procedures.
Thirty five healthy piglets (Landrace/White Large) of
both sexes, aged 12–16 weeks and weighing 25–35 kg
were studied. The animals were fasted overnight but had
free access to water. All pigs were premedicated with mid-
azolame and atropine (0.1 mg/kg IM) one hour before
anesthesia. Anesthesia was induced with an intravenous
bolus of propofol (1 mg/kg) and fentanyl (0.05 mg) via the
lateral auricular vein. After endotracheal intubation,
the pigs were ventilated with a volume-control ventila-
tor (TAEMA Clarys 2000) with FiO2 0.65, tidal volume
10 ml/kg and respiratory rate adjusted for normocap-
nia. Correct placement of the tracheal tube was ascer-
tained with inflation and auscultation of both lungs.
The tracheal tube was secured at the mouth with a tie.
To prevent agonal gasping and its possible interactions
with pulmonary and hemodynamic variables during
cardiac arrest, muscle paralysis was achieved with cis-
atracurium (20 mg) after intubation with additional
doses as needed.
Anesthesia was maintained with a continuous infusion
of midazolame (5 μg/kg/min). Standard lead II electrocar-
diagraphic (ECG) traces and systemic arterial blood pres-
sure were monitored continuously (FUKUDA DENCHY
Datascope expert DS-5300 W). For continuous measure-
ment of arterial oxygenation (SpO2), a pulse oxymeter was
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were measured in arterial blood. Body temperature
was controlled with a heating pad aiming for a core
temperature of 38°C.
After a surgical plan of anesthesia was obtained, the
right external jugular vein, right carotid and left internal
jugular vein were isolated by cut down technique and
introducer sheath were placed in each. The left external
jugular vein was used for fluid and drug administration.
Calibrated micromanometer-tipped catheters (Millar)
were placed into the ascending aorta and right atrium
via the right carotid artery and right external jugular
vein, respectively. Access to the heart for open chest car-
diac compressions was achieved through a midline ster-
notomy. Access to abdominal aorta and inferior vena
cava (IVC) was achieved through a retroperitoneal
approach.
NIRS measurements
The principles of NIRS function and the vascular occlu-
sion technique (VOT) have been described elsewhere
[18,19]. In short, NIRS function is based on the capacity
of chromophores in tissues (mainly hemoglobin) to absorb
light at the infrared region (680–800 nm), depending on
the oxygen saturation of hemoglobin (Hb). Differences in
the absorption spectra of hemoglobin make it possible for
the NIRS methodology to estimate the percentage of oxy-
genated hemoglobin over the total hemoglobin in the
underlying tissue volume, i.e. the tissue oxygen saturation
(StO2), as well as an approximation of the total tissue Hb
content.Figure 1 NIRS tracings at baseline and during the vascular occlusionWe placed the NIRS probe firmly on a well trimmed
and shaved skin area at the medial aspect of the femur
of the right rear limb. Underneath are the gracilis, semi-
membranosis and adductor muscles. This positioning re-
sembles the positioning of the NIRS sensor over the
quadriceps femoris muscle in humans, as in a previous
study [20]. The light transmitted from the probe has a
penetration depth of approximately 25 mm, which en-
ables the measurement of StO2 in the corresponding
muscle. StO2 was measured using the wide-gap, second-
derivative NIRS (InSpectra Tissue Spectrometer, Model
325, Hutchinson Technology Inc., Hutchinson, MN,
USA). Estimation of tissue oxygenation by NIRS was
performed before and after LPS administration. After an
initial resting StO2 value had been recorded, the VOT
test was performed (Figure 1): inferior vena cava and ab-
dominal aorta were accessed by a retroperitoneal ap-
proach. Vascular occlusion was performed with a curved
forceps and remained for 3 minutes. Then occlusion was
rapidly released, producing the reperfusion and the
hyperemia phase. StO2 was measured continuously dur-
ing all phases of VOT. Finally, StO2 values were again
stabilized to a post-VOT resting level.
VOT-derived StO2 parameters were analyzed off-line,
blindly and in random order, using the InSpectra software
(InSpectra Analysis Program, version 2.0; Hutchinson
Technology; Hutchinson, MN). The first degree slope of
the hemoglobin desaturation curve, during stagnant limb
ischemia, reflects the tissue oxygen consumption rate
(OCR,%/min). The slope of the increase of StO2, after
release of the vascular occlusion (reperfusion rate, RR,test.
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hyperemia, RH,%) are indicative of endothelial function
and vascular reactivity.
Experimental protocol
Animals were randomly assigned into three groups: group
A (8 animals), group B (14 animals) and group C (13
animals). Figure 2 depicts the timeline of the experimental
protocol. Following surgical preparation and thirty
minutes resting period, baseline measurements were
performed. In order to assess tissue oxygenation we
implemented NIRS with VOT in thirteen piglets of the
groups B and C (5 animals from group B and 8 from
group C). Subsequently, as far as group A is concerned,
100 ml of normal saline were administered in a thirty
minutes period. 100 μg/kg of lipopolysaccharide (LPS;
62325 lipopolysaccharide from E.coli serotype O11:B4;
Fluca Buchs, Switzerland) was administered in a period
of thirty minutes to the piglets of group B and C. New
measurements were obtained. NIRS measurements were
performed at the piglets that were previously tested. A
50-Hz, 60-V alternating current applied to epicardium
was used to induce ventricular fibrillation (VF). VF was
confirmed by the typical ECG rhythm and the precipi-
tous decrease in arterial pressure. Then, mechanical
ventilation was discontinued.
After three minutes of untreated VF, open chest CPR
was performed manually and mechanical ventilation wasFigure 2 Timeline of the experimental protocol. Following surgical prep
were performed. Subsequently, 100 ml of normal saline or 100 μg/kg of lip
measurements were obtained. Ventricular fibrillation (VF) was induced and
untreated VF, open chest CPR was performed manually and mechanical ve
defibrillation was attempted using 50 joules, followed by two minutes of o
VF. Before the third defibrillation, the animals of group A and B received 1
current guidelines for the treatment of cardiac arrest were followed, for theresumed using identical ventilation variables as before
cardiac arrest. The chest compression rate was 100/min
with the thumb of the right hand placed on the left ven-
tricle while the fingers encircled the right ventricle. All
chest compressions were performed by the same investi-
gator and were metronome guided.
Ten minutes after the induction of VF, defibrillation
(NIHON Kohben corporation, TEC-7200 K) was attempted
using 50 joules, followed by two minutes of open chest
CPR. In case the piglets did not restore an organized car-
diac rhythm and circulation, a second defibrillation was
attempted followed by two minutes of CPR again.
For groups A and B we used 1 mg of EP before the 3d
defibrillation. Subsequently, we used 1 mg of EP every
two cycles (every cycle consists of two minutes of CPR)
if VF persisted. If not, we used the algorithm of European
Resuscitation Council (ERC), regarding the defibrillable
and non-defibrillable rhythms.
For group C we used 0.4 U/kg of AVP before the 3d
defibrillation. After that we used 1 mg of EP every two
cycles (of two minutes of CPR) if VF persisted. If not, we
used the algorithm of ERC, regarding the defibrillable
and non-defibrillable rhythms.
The vasopressor drugs were infused with a bolus of a
crystalloid solution after the administration.
End point for the experiment was ROSC, defined as
an organized cardiac rhythm with a mean aortic pressure
(MAP) of more than 60 mmHg, lasting for at least fivearation and thirty minutes resting period, baseline measurements
opolysaccharide were administered in a thirty minutes period. New
mechanical ventilation was discontinued. After three minutes of
ntilation was resumed. Ten minutes after the induction of VF,
pen chest CPR. Defibrillation was performed again in case of remaining
mg EP whereas the piglets of group C received 0.4 U/kg AVP. The
rest of the protocol.
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35 minutes after induction of VF, then CPR was stopped
(piglets not survived).
Statistical analysis
Continuous variables were tested for normality of distri-
bution with Shapiro-Wilk test. Pearson’s chi squared test
was used for comparisons of categorical variables and
paired samples t-test or Wilcoxon signed ranks test (in
case of not normal distribution) for continuous variables.
Independent samples t-test or Mann–Whitney signed
ranks test were employed to check for between-group dif-
ferences of continuous variables at baseline. Statistical sig-
nificance was considered at P < 0.05. Data are expressed as
means ± standard deviation or as numbers (percentage).
Binary logistic regression analysis was used to investigate
differences in ROSC between control (group A) and LPS
treated animals (groups B and C). All analyses were con-
ducted using SPSS version 17.0 (SPSS Inc, Chicago, IL,
USA).
Results
Basic characteristics of the piglets are demonstrated in
Table 1. None of the piglets regained spontaneous circu-
lation without defibrillation. In Group A, one regained
spontaneous circulation after the 1st defibrillation and
one after the 2nd defibrillation. In Group B, one regained
spontaneous circulation after the 1st defibrillation and
one after the 2nd defibrillation. In Group C, one regainedTable 1 Basic characteristics of the piglets in the
three groups
Variables Group A (N = 8) Group B (N = 14) Group C (N = 13)
Male/female 3/5 8/6 6/7
Weight, kg 27 ± 2 27 ± 2 29 ± 2
HR, bpm 112 ± 26 113 ± 29 97 ± 10
MAP, mmHg 87 ± 13 94 ± 26 89 ± 23
CVP, mmHg 9 ± 5 6 ± 3 7 ± 2
Hct,% 27 ± 7 27 ± 6 27 ± 6
SpO2,% 99 ± 1 99 ± 1 99 ± 2
PO2, mmHg 334 ± 138 237 ± 85 243 ± 101
PCO2, mmHg 63 ± 31 43 ± 21 42 ± 17
pH 7.29 ± 0.16 7.46 ± 0.17† 7.43 ± 0.13*
HCO3, mmol/L 28 ± 3 27 ± 3 26 ± 3
K, mmol/L 3.5 ± 0.4 3.6 ± 0.5 3.7 ± 0.5
Na, mmol/L 143 ± 3 144 ± 3 141 ± 5
Ca, mmol/L 1.3 ± 0.4 1.1 ± 0.2 1.1 ± 0.2
Data are means ± SD.
HR: heart rate; MAP: mean arterial pressure; CVP: central venous pressure; Hct:
hematocrit; SpO2: arterial oxygen saturation; PO2: arterial partial pressure of
oxygen; PCO2: arterial partial pressure of carbon dioxide.
*P < 0.05: comparison between group C and A.
†P < 0.05: comparison between group B and A.spontaneous circulation after the 2nd defibrillation. Vaso-
pressors were administered during CPR in animals that
were not resuscitated after two defibrillations.
The values (median and minimum-maximum value) of
the number of CPR cycles performed in groups A, B and
C were 4.5 (2–12), 6.5 (2–12) and 10 (3–12) respectively.
Also, the values (median and minimum-maximum
value) of the number of EP doses administered during
resuscitation in groups A, B and C were 3 (1–4), 3 (1–7)
and 4.5 (0–7) respectively.
Survival rates differed significantly (P = 0.046) between
the piglets of group A and those of pooled LPS-treated
groups, B and C (Table 2). The difference between
groups A and C did not reach statistical significance
(P = 0.063). No difference was established between groups
B and C (P = 0.55).
After LPS administration MAP and heart rate (HR)
did not change (89 ± 22 vs 82 ± 22 mmHg, 105 ± 22 vs
102 ± 26 bpm respectively, P > 0.05) while central venous
pressure (CVP) slightly increased (6 ± 2 vs 7 ± 3 mmHg,
P = 0.033).
Differences of laboratory variables (such as pH, PCO2,
PO2, Hct, Na, K, Ca, HCO3, SpO2) of groups B and C,
before and after LPS infusion, are shown in Table 3. pH,
HCO3 and PO2 were significantly, although slightly, de-
creased after LPS administration.
The comparison between dynamic oxygenation indices
obtained by NIRS, before and after the endotoxin infu-
sion, is depicted in Table 4. Although we applied NIRS
in thirteen piglets, analysis of the results was not carried
out in all animals that where tested, for technical rea-
sons of the analysis procedure. OCR decreased after the
septic insult; however the difference did not reach a sta-
tistically significant level (P = 0.07).
In order to check whether the occlusion of IVC and
abdominal aorta for NIRS measurements could affect
survival negatively, we compared the LPS-treated piglets
that were estimated or not by NIRS. No difference was
noted in relation to survival rate (p = 0.18) between the
LPS-treated piglets subjected to the VOT procedure (6 out
of 13 survived) compared with the ones that were not
subjected (3 out of 14 survived).
Discussion
In the present study the chance of ROSC after CA in an
endotoxemic porcine model was reduced compared with
non-LPS-treated animals. AVP administration, substitutingTable 2 Survival rate in the three piglet groups
Survived Not survived Sum Survival rate %
Group Α 6 2 8 75
Group Β 5 9 14 36
Group C 4 9 13 31
Table 3 Comparison of laboratory variables before and
after LPS infusion
Variables Before LPS (N = 27) After LPS (N = 27) P
pH 7.45 ± 0.15 7.40 ± 0.13 0.04
PO2, mmHg 240 ± 93 204 ± 111 0.04
PCO2, mmHg 42 ± 19 43 ± 16 ns
HCO3, mmHg 26.8 ± 3.2 25.1 ± 3.0 < 0.01
Hct,% 26.9 ± 6.2 27.8 ± 5.7 ns
Na, mmol/L 143 ± 5 143 ± 3 ns
K, mmol/L 3.6 ± 0.5 3.8 ± 0.8 ns
Ca, mmol/L 1.06 ± 0.19 1.16 ± 0.23 0.06
SpO2,% 99 ± 1 97 ± 6 ns
Pooled results for both B and C groups. Data are means ± SD.
PO2: arterial partial pressure of oxygen; PCO2: arterial partial pressure of
carbon dioxide; HCO3: bicarbonate concentration in blood; Hct: hematocrit;
SpO2: arterial oxygen saturation.
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outcome.
The results of studies investigating the effectiveness of
AVP (alone or in combination with EP), either in restor-
ing spontaneous circulation after CA or regarding the
long-term survival and the neurologic recovery, have
been inconsistent.
In a recent randomized study, patients with CA pre-
senting to or in the emergency department, were ran-
domly assigned to receive either 1 mg of EP or 40 U of
AVP and additional doses of EP. AVP improved out-
comes in patients with prolonged arrest times and
seemed to improve survival at admission [21].
However, most randomized, controlled trials failed to
prove any clear benefit for either drug administration over
the other [12,13] while recent studies question the ability
of EP to offer any overall benefit in CA patients [10].
In animal experiments although AVP seemed to be
superior to placebo or EP alone [22], improving
hemodynamic parameters, coronary perfusion pressure
and chance of ROSC [23], other studies have provided
contrasting results [24].
Concerning our septic model this is the first study to
provide an experimental confirmation of the adverse ef-
fect of sepsis on survival after arrest.Table 4 NIRS variables before and after administration
of LPS
Variables (N) Before LPS After LPS P
StO2,% (12) 66 ± 14 65 ± 15 0.72
OCR,%/min (12) 30 ± 30 19 ± 7 0.07
RR,%/min (9) 117 ± 66 119 ± 74 0.96
RH,% (10) 15.4 ± 13.4 13.6 ± 13.6 0.73
Pooled results for both B and C groups. Data are means ± SD.
StO2: tissue oxygen saturation; OCR: oxygen consumption rate estimated by
NIRS; RR: reperfusion rate; RH: reactive hyperemia.In the endotoxic environment created pre-CA, death
rate more than doubled. Adequate tissue oxygen delivery
and utilization, and avoidance of an untimely ATP deple-
tion seem essential for the heart, to resume an organized
rhythm during the advanced resuscitative treatment [9].
The decline of oxygen consumption rate after LPS ad-
ministration indicates that conditions of impaired aer-
obic metabolism begin to prevail in peripheral tissues,
early after the septic stimulus, before CA. The incipient
reduction of pH, HCO3 and PO2 can be viewed in the
same context.
In this septic background, AVP administration did not
improve the outcome in comparison to EP alone, as hy-
pothesized. Therefore the efficacy of AVP in endotoxemia
and sepsis is questioned although a recent meta-analysis
suggests that AVP administration could be beneficial in
septic shock [25], possibly due to a relative AVP deficiency
observed in septic states [26], in which, nitric oxide (NO)
production has a significant role [27,28].
AVP receptor blockade in endotoxic models resulted
in lower blood pressure than endotoxin alone [29]. Also,
AVP administration inhibited NO production induced
by LPS infusion [30] and restored LPS-induced vascular
hyporeactivity [31-33].
Although the above considerations can justify some
expectations relating to a potential benefit of an, at pri-
ority, AVP utilization in this special group of CA pa-
tients, the present study did not confirm a positive
outcome. Future research, with different study design,
dose and timing of AVP usage (e.g. late septic models),
is necessary to clarify the issue.
Of note, survival in LPS-treated piglets was not nega-
tively affected by the vascular occlusion procedure. Con-
trariwise, the piglets subjected to the VOT procedure
appeared to have a higher survival rate, which was not
statistically significant, likely due to the small sample
size.
This can be explained in the context of the ischemia-
reperfusion cardioprotective potential, broadly evaluated,
since it was shown that short ischemia-reperfusion cy-
cles protect the heart from a subsequent sustained ische-
mic insult [34]. Interestingly, a recent study in rats
demonstrated that limb ischemia preconditioning had a
protective effect in myocardial tissue subjected to ische-
mia for 30 min, followed by reperfusion [35].
Conclusions
The present study showed that in a septic porcine model
of CA, where VF was provoked soon after endotoxin ad-
ministration, chance of ROSC after resuscitation was sig-
nificantly reduced in the LPS-treated piglets compared to
healthy controls.
AVP administration during CPR, substituting the first
dose of EP, did not affect the outcome of septic animals.
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Some limitations should be mentioned: 1) In our study we
used LPS for the septic model. However intra-abdominal
infusion of autofeces is also an accepted model that would
be closer to a real clinical situation. 2) Pigs as small as 25–
35 kg is the kind we use in our laboratory. Although pigs
of this kind have been used in other experimental proto-
cols concerning resuscitation and other pathologies, ani-
mals of 60–70 kg would be more comparable to average
weighted patients. 3) It would be useful to test AVP in not
septic pigs and also to include a sham group. 4) The num-
ber of the piglets used was relatively small. 5) Our septic
model is limited in terms of severity and duration of sepsis
and the results could not be generalized to other cases of
more severe and protracted sepsis. 6) There are inherent
limitations of the NIRS method to estimate oxygenation
indices in peripheral tissue. 7) We did not perform NIRS
measurements in all piglets. However, the procedure did
not seem to negatively affect survival of septic animals.Key messages
 Pre-existing sepsis lowers the chance of ROSC after
CA.
 Adding AVP to EP administration, for CA occurring
early after a septic insult, does not seem to induce
any further benefit.
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